These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6141645)

  • 21. [The separate and combined use of timoptic depot].
    Egorov EA; Stavitskaia TV; Voĭtova SP
    Vestn Oftalmol; 1999; 115(3):28-30. PubMed ID: 10432851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: a six-month masked, multicenter trial in the United States. The United States Latanoprost Study Group.
    Camras CB
    Ophthalmology; 1996 Jan; 103(1):138-47. PubMed ID: 8628544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Timolol maleate 0.5% versus timolol maleate in gel forming solution 0.5% (Timolol GFS) in open angle glaucoma in India. Preliminary safety and efficacy study.
    Kumar H; Sudan R; Sethi HS; Sony P
    Indian J Ophthalmol; 2002 Mar; 50(1):21-3. PubMed ID: 12090082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Short-term effect of apraclonidine on intraocular pressure in glaucoma patients receiving timolol and pilocarpine.
    Yüksel N; Elibol O; Caglar Y; Alçelik T
    Ophthalmologica; 1997; 211(6):354-7. PubMed ID: 9380353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beta-adrenergic responsiveness of choroidal vasculature.
    Grajewski AL; Ferrari-Dileo G; Feuer WJ; Anderson DR
    Ophthalmology; 1991 Jun; 98(6):989-95. PubMed ID: 1678154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of Latanoprostene Bunod 0.024% Compared With Timolol 0.5% in Lowering Intraocular Pressure Over 24 Hours.
    Liu JHK; Slight JR; Vittitow JL; Scassellati Sforzolini B; Weinreb RN
    Am J Ophthalmol; 2016 Sep; 169():249-257. PubMed ID: 27457257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Meta-analysis of timolol on diurnal and nighttime intraocular pressure and blood pressure.
    Lee PW; Doyle A; Stewart JA; Kristoffersen CJ; Stewart WC
    Eur J Ophthalmol; 2010; 20(6):1035-41. PubMed ID: 20491052
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Brimonidine tartrate 0.2% twice daily vs timolol 0.5% twice daily: 1-year results in glaucoma patients. Brimonidine Study Group.
    Katz LJ
    Am J Ophthalmol; 1999 Jan; 127(1):20-6. PubMed ID: 9932994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 24-hour control of intraocular pressure with 2% dorzolamide/0.5% timolol fixed-combination ophthalmic solution in open-angle glaucoma.
    Feldman RM; Stewart RH; Stewart WC; Jia G; Smugar SS; Galet VA
    Curr Med Res Opin; 2008 Aug; 24(8):2403-12. PubMed ID: 18627642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prepared association of metipranolol 0.1% + pilocarpine 2% and of timolol 0.5% + pilocarpine 2%. Comparison of clinical efficacy and topical tolerability in the treatment of patients affected by POAG tonometrically uncontrolled with beta-blocker alone (two-centre study).
    Boles Carenini B; Brogliatti B; Dorigo MT; Vadalà G; Protti R; Bellone A
    Acta Ophthalmol Scand Suppl; 1997; (224):54-5. PubMed ID: 9589740
    [No Abstract]   [Full Text] [Related]  

  • 31. The effect of travoprost 0.004% as an adjuvant to timolol 0.5% therapy.
    Kovacić Z; Stanić R; Rogosić V; Bojić L; Ivanisević M; Capkun V
    Acta Clin Croat; 2009 Mar; 48(1):31-3. PubMed ID: 19623869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Analysis of the effectiveness of beta-blockers for intraocular pressure and visual field in primary open-angle glaucoma].
    Dobre X
    Oftalmologia; 2008; 52(4):95-9. PubMed ID: 19354170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prospects of using latanoprost, prostaglandin F2 alpha analog, in hypotensive therapy for glaucoma].
    Egorov EA; Nesterov AP; Romanova OV
    Vestn Oftalmol; 1998; 114(4):19-20. PubMed ID: 9771080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The efficacy and safety of the dorzolamide-timolol combination versus the concomitant administration of its components.
    Strohmaier K; Snyder E; DuBiner H; Adamsons I
    Ophthalmology; 1999 Dec; 106(12 Suppl):1-9. PubMed ID: 10598691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension. The Latanoprost Study Group.
    Watson P; Stjernschantz J
    Ophthalmology; 1996 Jan; 103(1):126-37. PubMed ID: 8628543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The usefulness of dapiprazole, an alpha-adrenergic blocking agent, in pigmentary glaucoma.
    Mastropasqua L; Carpineto P; Ciancaglini M; Gallenga PE
    Ophthalmic Surg Lasers; 1996 Sep; 27(9):806-9. PubMed ID: 8878205
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intraocular pressure-lowering efficacy of brinzolamide 1%/timolol 0.5% fixed combination compared with brinzolamide 1% and timolol 0.5%.
    Kaback M; Scoper SV; Arzeno G; James JE; Hua SY; Salem C; Dickerson JE; Landry TA; Bergamini MV;
    Ophthalmology; 2008 Oct; 115(10):1728-34, 1734.e1-2. PubMed ID: 18538406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A double-masked randomized comparison of the efficacy and safety of unoprostone with timolol and betaxolol in patients with primary open-angle glaucoma including pseudoexfoliation glaucoma or ocular hypertension. 6 month data.
    Nordmann JP; Mertz B; Yannoulis NC; Schwenninger C; Kapik B; Shams N;
    Am J Ophthalmol; 2002 Jan; 133(1):1-10. PubMed ID: 11755834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of changing from concomitant timolol pilocarpine to bimatoprost monotherapy on ocular blood flow and IOP in primary chronic angle closure glaucoma.
    Agarwal HC; Gupta V; Sihota R
    J Ocul Pharmacol Ther; 2003 Apr; 19(2):105-12. PubMed ID: 12804055
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of glaucoma with beta receptor blockers. Significance of adrenergic receptors of the beta-2 subtype for their effect on intraocular pressure].
    Noack E
    Ophthalmologica; 1988; 196(2):76-81. PubMed ID: 2896327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.